Real-world efficacy and safety of Upadacitinib in IBD patients. Preliminary data from the Apulian Network for Inflammatory Bowel Disease (AN-IBD)

被引：0

作者：

Bossa, F. ^{[1
]}

Principi, M. B. ^{[2
]}

Marzo, M. ^{[3
]}

Stasi, E. ^{[4
]}

Mazzuoli, S. ^{[5
]}

Pranzo, G. ^{[6
]}

Sacco, R. ^{[7
]}

Fanigliulo, L. ^{[8
]}

Neve, V ^{[9
]}

Tursi, A. ^{[10
]}

Rizzi, M. ^{[11
]}

Bringiotti, R. ^{[12
]}

Bucci, A. ^{[13
]}

Allegretta, L. ^{[14
]}

Contaldo, A. ^{[15
]}

Mastronardi, M. ^{[16
]}

De Tullio, N. ^{[17
]}

Hadad, Y. ^{[18
]}

Annese, M. ^{[19
]}

Delll'Aquila, P. ^{[2
]}

Palmisano, C. M. ^{[2
]}

Paiano, P. ^{[3
]}

Facciorusso, A. ^{[4
]}

Rima, R. ^{[4
]}

Guglielmi, F. W. ^{[20
]}

Sgarro, C. ^{[7
]}

Perri, F. ^{[19
]}

机构：

[1] IRCCS Casa Sollievo Sofferenza, Dept Gastroenterol & Digest Endoscopy, San Giovanni Rotondo, Italy

[2] Univ Bari, Dept Precis & Regenerat Med & Ionian Area DiMePRe, Gastroenterol Unit, Gastroenterol, Bari, Italy

[3] Osped Veris delli Ponti, UOC Gastroenterol, Gastroenterol, Scorrano, Italy

[4] Gastroenterol & Endoscopia Digest Osped Vito Fazzi, Gastroenterol, Lecce, Italy

[5] Osped Di Miccoli, UOC Gastroenterol, Gastroenterol, Barletta, Italy

[6] Martina Franca Hosp, Digest Endoscopy Unit, Surg, Martina Franca, Italy

[7] Foggia Univ Hosp, Gastroenterol & Digest Endoscopy Unit, Gastroenterol, Foggia, Italy

[8] SS Annunziata Hosp, Div Gastroenterol, Gastroenterol, Taranto, Italy

[9] Div Gastroenterol, Gastroenterol, Brindisi, Italy

[10] ASL BAT, Serv Gastroenterol Terr, Gastroenterol, DSS Barletta 4, DSS 4 Barletta, Andria, Italy

[11] Osped Murgia Fabio Perinei, UOSD Endoscopia Digest, Gastroenterol, Altamura, Italy

[12] Osped Venere, UO Endoscopia Digest, Gastroenterol, Bari, Italy

[13] UOC Gastroenterol & Endoscopia Digest, Gastroenterol, Bari, Italy

[14] Osped Santa Caterina Novella, UOC Gastroenterol & Endoscopia Digest, Gastroenterol, Galatina, Italy

[15] IRCCS Saverio De Bellis, UOC Gastroenterol Endoscopia Digest, Gastroenterol, Castellana Grotte, Italy

[16] IRCCS Saverio De Bellis, UOSD IBD, Gastroenterol, Castellana Grotte, Italy

[17] Osped Miulli, UOC Gastroenterol & Endoscopia Digest, Gastroenterol, Acquaviva Delle Fonti, Italy

[18] Osped Cardinale Giovanni Pan, UOC Med Interna, Internal Med, Tricase, Italy

[19] IRCCS, Fdn Casa Sollievo Sofferenza, UOC Gastroenterol & Endoscopia Digest, Gastroenterol, San Giovanni Rotondo, Italy

[20] Osped Di Miccoli, Gastroenterol, UOC Gastroenterol Barletta, Barletta, Italy

来源：

JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷

关键词：

D O I：

10.1093/ecco-jcc/jjae190.0916

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P0742

引用

页码：i1439 / i1439

页数：1

共 50 条

[21] Subclinical signs in ocular asymptomatic inflammatory bowel disease (IBD) patients.
Alvisi, C
Di Maria, A
Perego, M
Ruberto, G
Frego, R
Centenara, L
Klersy, C
GASTROENTEROLOGY, 1998, 114 (04) : A919 - A919
[22] Effectiveness of Upadacitinib for Inflammatory Bowel Disease Patients With Pouchitis: Prospective Real-World Experience
Cleveland, Noa Krugliak
Choi, Natalie
Choi, David K.
Dalal, Sushila
Rubin, David T.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S873 - S874
[23] REAL-WORLD TRENDS IN CLINICAL CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS INITIATING VEDOLIZUMAB OVER TIME IN ISRAEL
Weil, C.
Chodick, G.
Shalev, V
Demuth, D.
Petrakis, I
Ben Baruch, O.
Tsukinovsky, S.
Yarden, A.
VALUE IN HEALTH, 2018, 21 : S142 - S142
[24] Switching Vedolizumab from IV to SC Injection in Inflammatory Bowel Disease Patients with Active Disease: Real-World Experience from a German IBD Cohort
Kubesch, Alica
Kruse, Nina
Jungheim, Florian
Balaban, Uemniye
Stratmann, Katharina
Sprinzl, Kathrin
Dienethal, Antje
Krause, Thomas
Zeuzem, Stefan
Blumenstein, Irina
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
[25] Safety and Efficacy of the Fuse-System in Patients With Inflammatory Bowel Disease (IBD) and Infectious Colitis
Neumann, Helmut
Thieringer, Florian
Rahman, Khan Fareed
Tontini, Gian Eugenio
Monkemuller, Klaus E.
Galle, Peter R.
GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB269 - AB269
[26] EFFICACY AND SAFETY OF AZATHIOPRINE (AZA) IN CHILDREN WITH INFLAMMATORY BOWEL-DISEASE (IBD)
VERHAVE, M
WINTER, HS
GRAND, RJ
GASTROENTEROLOGY, 1987, 92 (05) : 1682 - 1682
[27] A real-world longitudinal study implementing digital screening and treatment for distress in inflammatory bowel disease (IBD): The COMPASS-IBD study protocol
Jones, Annie S. K.
Harding, Sophie
Seaton, Natasha
Hudson, Joanna L.
Duff, Alexa
Wroe, Abigail
Singh, Harinder
Norton, Sam
Picariello, Federica
Moss-Morris, Rona
CONTEMPORARY CLINICAL TRIALS, 2024, 145
[28] Real-world pattern of inflammatory bowel disease (IBD), raised faecal calprotectin and IBD red flags in patients with moderate-to-severe psoriasis: interim results from the EPIC study
Warren, Richard B.
Ghosh, Subrata
Carter, Ben
Bartlett, Sean
Powles, Emma
Millward, Rachael
Watcham, Shelley
Blanthorn-Hazell, Sophee
Crooks, James
Hansell, Chris
Millar, Julie
Williams, Claire
Migas, Sylwia
Hajne, Joanna
Hayee, Bu
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 42 - 42
[29] IBD Has No Age: Preliminary results of an international survey among older patients with Inflammatory Bowel Disease (IBD)
Fons, A.
Girardi, P.
Savini, C.
Maljaars, J.
Haaf, I.
Avedano, L.
Asscher, V.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2097 - I2098
[30] Abnormalities found in unaffected identical twins of inflammatory bowel disease (IBD) patients.
Subhani, JM
Gordon, F
Sercombe, J
Walmsley, R
Bridger, S
Bjarnason, I
Macpherson, A
Montgomery, SM
Wakefield, AJ
GASTROENTEROLOGY, 1999, 116 (04) : A826 - A826

← 1 2 3 4 5 →